Announcing a $15.5 million grant from Cancer Prevention and Research Institute of Texas (CPRIT) to advance our development of IMGS-001, the dual-specific checkpoint inhibitor and tumor microenvironment remodeling agent.
Read moreExcited about what you see?
Learn more